Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Journal:
Current Molecular Pharmacology
Volume:
2
Page:
263-284
Author(s):
L. Oliver, C. Olivier, F. B. Marhuenda, M. Campone and F. M. Vallette
Methionine-Derived Metabolites in Apoptosis: Therapeutic Opportunities for Inhibitors of their Metabolism in Chemoresistant Cancer Cells
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3686-3700
Author(s):
G. Quash and G. Fournet
Role of Chemokines and Their Receptors in Cancer
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3396-3416
Author(s):
Roeliene C. Kruizinga, Jovanka Bestebroer, Paul Berghuis, Carla J.C. de Haas, Thera P. Links, Elisabeth G.E. de Vries and Annemiek M.E. Walenkamp
Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3797-3804
Author(s):
Ch. Gialeli, D. Kletsas, D. Mavroudis, H. P. Kalofonos, G. N. Tzanakakis and N. K. Karamanos
Role of Nuclear Steroid Receptors in Apoptosis
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3886-3902
Author(s):
Joana D. Amaral, Susana Sola, Clifford J. Steer and Cecília M.P. Rodrigues
Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3577-3589
Author(s):
D. Leali, P. Alessi, D. Coltrini, M. Rusnati, L. Zetta and M. Presta
Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3943-3965
Author(s):
L. G. Korkina, C. De Luca, V. A. Kostyuk and S. Pastore
Proteasome Inhibitors in Cancer Therapy
Journal:
Current Drug Targets
Volume:
10
Page:
968-981
Author(s):
Ugo Testa
Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Journal:
Current Gene Therapy
Volume:
9
Page:
356-367
Author(s):
Ann-Marie Maatta, Haritha Samaranayake, Jere Pikkarainen, Thomas Wirth and Seppo Yla-Herttuala
Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
Journal:
Current Gene Therapy
Volume:
9
Page:
368-374
Author(s):
Pedro R. Lowenstein and Maria G. Castro